MedPath
NMPA Approval

Lidocaine Hydrochloride Powder Intradermal Injection System

国药准字HJ20220012

powder pharmaceuticals, inc.

March 1, 2022

Drug Information

盐酸利多卡因粉末无针注射皮内给药系统

注射剂

0.5mg

化学药品

March 1, 2022

February 28, 2027

Company Information

Applicant Company

powder pharmaceuticals, inc.

Unit G01-G03, Ground Floor, Wireless Centre, Hong Kong Science Park, Shatin, New Territories, HONG KONG ,CHINA

Manufacturing Company

powder pharmaceuticals, inc.

Unit G01-G03, Ground Floor, Wireless Centre, Hong Kong Science Park, Shatin, New Territories, HONG KONG ,CHINA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸利多卡因粉末无针注射皮内给药系统 - NMPA 批准文号 | MedPath